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MYPLAN –mobile phone application to
manage crisis of persons at risk of suicide:
study protocol for a randomized controlled
trial
Kate Andreasson1* , Jesper Krogh2, Per Bech1, Hanne Frandsen2, Niels Buus3, Barbara Stanley4, Ad Kerkhof5,
Merete Nordentoft2,6 and Annette Erlangsen2,7,8
Abstract
Background: Persons with a past episode of self-harm or severe suicidal ideation are at elevated risk of self-harm as
well as dying by suicide. It is well established that suicidal ideation fluctuates over time.
Previous studies have shown that a personal safety plan can assist in providing support, when a person experiences
suicide ideation, and help seeking professional assistance if needed. The aim of the trial is to determine whether a
newly developed safety mobile app is more effective in reducing suicide ideation and other symptoms, compared to a
safety plan on paper.
Methods/design: The trial is designed as a two-arm, observer-blinded, parallel-group randomized clinical superiority
trial, where participants will either receive: (1) Experimental intervention: the safety plan provided as the app MyPlan, or
(2) Treatment as Usual: the safety plan in the original paper format. Based on a power calculation, a total of 546
participants, 273 in each arm will be included. They will be recruited from Danish Suicide Prevention Clinics. Both
groups will receive standard psychosocial therapeutic care, up to 8–10 sessions of supportive psychotherapy. Primary
outcome will be reduction in suicide ideation after 12 months. Follow-up interviews will be conducted at 3, 6, 9, and
12 months after date of inclusion.
Discussion: A safety plan is a mandatory part of the treatment in the Suicide Prevention Clinics in Demark. There are
no studies investigating the effectiveness of a safety plan app compared to a safety plan on paper on reducing suicide
ideation in patients with suicide ideation and suicidal behavior. The trial will gain new knowledge of whether modern
technology can augment the effects of traditional personalized safety planning.
Trial registration: ClinicalTrials.gov, NCT02877316. Registered on 19 August 2016.
Keywords: Suicide prevention, RCT, Safety plan, Suicide ideation, Suicide behavior
Background
In Denmark, there are 8000–10,000 people attempting
suicide on a yearly basis [1]. A recent Danish nationwide
register study (1994–2011) showed that the average
incidence rates for women and men were 130.7 (95% CI
= 129.6–131.8) per 100,000 and 86.9 (95% CI = 86.0–
87.8) per 100,000, respectively [2]. Suicide ideation is a
part of a continuum where initial suicidal ideation might
develop into concrete plans and actions; depending on
the suicidal intent, actions might end as self-harm or
death by suicide [3].
A strategy to prevent suicidal behavior is to avoid or
reduce suicide ideation. i.e., to secure better control of
painful thoughts and thereby of suicidal behavior. This is
supported by the model of “the suicidal continuum”
suggested by Maris et al., which describes the relations
between suicide ideation, suicide plan, attempts, and
completed suicide [3].
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The safety planning tool [4], as developed by Stanley
and Brown, was originally intended as a brief intervention
for persons who present at an emergency department
(ED) with suicidal ideation. Together with the patient, the
clinician identifies warning signs that a suicidal crisis is
underway as well as personalized strategies that might
resolve the crisis. A written version of a crisis plan includ-
ing contact details for family, friends, and professionals is
given to the patient; ideally the patient would resort to the
safety plan in times of crisis. Using a safety plan can be
considered as a therapeutic intervention in itself. Users
have acknowledged that a safety plan is useful and not
linked to adverse outcomes [5, 6]. The safety plan has
been developed as a cognitive therapeutic intervention [4].
The aim of identifying proximal thoughts, images, and
core beliefs activated prior to the suicidal ideation or
attempt may introduce self-monitoring of the triggers for
a “suicidal mode” [4, 7]. Hence, application of cognitive
and behavioral strategies may help develop adaptive strat-
egies for coping with stressors and maneuvering a suicidal
crisis [5, 6, 8]. The safety plan consists of basic compo-
nents which will allow the user to: (1) recognize warning
symptoms /signs of an upcoming suicidal crisis; (2) work
with internal coping strategies; (3) become distracted from
suicidal thoughts, for instance, though their social net-
work [4]; and (4) remove access to lethal means. The
safety plan in a paper version is considered as good med-
ical practice and has become a mandatory part of the
treatment in Danish Suicide Prevention Clinics. Some pa-
tients keep the safety plan visible, e.g., on the refrigerator,
while others choose to hide it away. Storing the paper ver-
sion of the safety plan might imply that the safety plan will
not available or “at hand” when a suicidal crisis arises.
Usage of modern technologies has grown, especially in
younger generations; ownership and use of smartphones
increase on a yearly basis. It is estimated that 82% of the
Danish population owned a smartphone in 2016, which was
a 49% increase from 2011 [9]. A smartphone is generally ”at
hand,” and this makes it very useful with respect to man-
aging a suicidal crisis. The World Health Organization
(WHO) recommends mobile devices as an option for pro-
viding support and therapy to people at risk of suicide [10].
Many mental health apps evaluated in randomized con-
trolled studies were not publicly available [11], but psychi-
atric patients aged 45 years or younger indicated they were
interested in using smartphone apps to monitor their mental
health [12]. Although smartphones are increasingly used, we
still need evidence-based documentation for their effect on
mental health challenges, such as suicide prevention.
A systematic review of smartphone tools for suicide
prevention identified 123 different apps for the Android
and iPhone [13]. Of these, 49 included interactive fea-
tures, mainly (n = 27) focusing on getting support from
family and friends, while 14 enlisted a safety planning
feature. The safety plan apps contained multiple compo-
nents, such as apps connecting to the user’s contact/ad-
dress book, crisis support information, and sections
allowing users to identify their individual warning signs
and to reduce lethal means in their surroundings [13].
The authors of the review concluded that the impact of
these apps still remains to be assessed.
MyPlan, an electronic, app-based version of the safety
plan tool, was developed in 2012 for smartphones [14].
Like the original paper-based version [4], MyPlan was cre-
ated with the intention of being a self-help tool for the
management of suicidal crisis. The app consists of ”empty
spaces” where the user enters information regarding his or
her own ”symptoms” of suicidal crisis, which can be linked
to individualized ”strategies” for coping. It also includes
direct links to selected contact persons, hotlines, and map
directions to the nearest ED [14]. Myplan, which is also
available in Norwegian, has been tested extensively by
users and clinical staff. So far, no study has tested whether
an app-based, electronic version of a safety plan is linked
to reductions in suicide ideation and behavior, which is
the focus of this trial. MyPlan was updated in 2015-2016
with the aim of further integrating the satefy plan with
smartphone features and technologies. A user involving
approach was taken and four focus groups were con-
ducted with (1) young adult users, (2) adult users, (3) next
of kin, and (4) health care professionals on the pros and
cons of using the app. Furthermore, two workshops were
held with adult users concerning the updated design of
the app, including its functionalities. Feedback from the
focus groups and the workshops indicated that the
MyPlan was relevantly addressing users’ needs in suicidal
crises. However, they also provided helpful suggestions re-
garding improvements that were taken into account when
the app was updated.
As a suicide preventive measure, the Danish Health Au-
thority established Suicide Prevention Clinics nationwide
in 2006. The clinics offer highly specialized short-term
supportive psychotherapy and social counseling for pa-
tients at risk of suicide in an outpatient setting. The target
group is a subsample of all persons with severe suicide
ideation or self-harm, as the clinics focus on patients who
do not have severe underlying psychiatric disorders that
require psychiatric admission or specialized treatment
[15]. Some clinics are specialized in treating children and
adolescents and offer support to patients as young as
10 years of age, but the majority of clinics focus on adoles-
cents and adults. Evaluations of the psychosocial therapy
provided in the Suicide Prevention Clinics have linked it
to reductions in repeated suicide attempt, deaths by sui-
cide, and deaths due to other causes [15, 16].
The purpose of this trial is to investigate if a safety plan-
ning tool delivered as an app, compared to a safety plan
delivered by paper, can reduce suicide ideation, as
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measured with the Beck Suicide Ideation Scale (BSS), after
12 months intervention in patients referred to Suicide
Prevention Clinics. Our underlying hypothesis is that an
app-based safety plan is more effective than a paper ver-
sion based on its availability and mobile phone technol-
ogy. The availability of the safety plan makes it feasible for
the patient to continue working with suicidal triggers,
coping strategies, and developing new strategies in the
app as well as continuously revising them. Furthermore,
the app offers features of distraction such as links to pho-
tos, music, videos, YouTube videos, and homepages that
all may be linked to individual strategies. Additional fea-
tures include (1) a map function with the current location
and nearest ED (as an aid in a crisis situation), (2) prewrit-
ten messages that can be sent during difficult situations to
facilitate contact and communication with others before a
suicidal crisis, (3) direct phone links to selected contacts,
for instance 24/7 crisis support, emergency services,
friends and family, (4) access to a list of other app users'
strategies for inspiration, and (5) a virtual hope box.
Methods/design
The trial is designed as a multi-site, two-arm, parallel-
group, observer-blinded randomized clinical superiority
trial. Based on the power calculation listed below, a total of
546 participants, 273 in each arm, will be recruited from
seven of the national Suicide Prevention Clinics. Both
groups will receive treatment as usual (TAU) consisting of
short-term psychosocial therapy. A safety plan is an integral
part of the treatment provided in the Suicide Prevention
Clinics; in collaboration with the therapist, all patients will
set up a safety plan during one of their first sessions.
Recruitment and criteria for inclusion and exclusion
All participants will be recruited through the Suicide Pre-
vention Clinics in Denmark. A total of seven clinics and
their satellite sites have confirmed to participate in the
trial. Patients are typically referred to the clinics from som-
atic and psychiatric EDs after a self-harm episode; however,
general practitioners’ and self-referrals are also accepted.
Inclusion and exclusion criteria
There is no age restriction on participation in the study,
as the Suicide Prevention Clinics also offer treatment for
children and adolescents where the safety plan is a regu-
lar feature. To be included, participants must have a
smartphone (iPhone or Android phone) and understand
sufficient Danish to use MyPlan. Finally, the participant
will be provided with written and verbal information
about the study and will consent by signing a form.
There are no exclusion criteria in the trial. The pa-
tients receiving short-term treatment in the Suicide Pre-
vention Clinics represent a select group who are
identified as being at risk of suicide. Patients with severe
mental disorders for which other, more specialized treat-
ment programs exist, such as depression, anxiety, and
personality disorder, are not seen in the clinics. Similarly,
patients with alcohol and drug abuse disorders are of-
fered treatment by community-based service providers.
Enrollment and randomization
At the first visits to the Suicide Prevention Clinic, eligible
participants will receive oral and written information
about the study as well as an information flyer. They will
be offered time for consideration and the option of a later
appointment where a relative may accompany the person
before a decision of whether to enter the trial is made. A
flyer dedicated to parents or guardians of children and ad-
olescents attending the clinic has been developed in order
to secure consent from patients where parental
authorization is required. After consenting, patients who
fulfill the inclusion criteria and none of the exclusion
criteria will be randomized using a computer-generated
sequence randomization to either (1) TAU and MyPlan or
(2) TAU and the paper version of the safety plan. The
randomization will be stratified by gender and previous
self-harm (yes/no) and will be facilitated through an
external, centrally administered Internet program. The
clinicians working at the Suicide Prevention Clinics will,
by accessing the Internet, obtain information regarding
patient allocation immediately after the signed informed
consent has been provided. This procedure will ensure
adequate allocation concealment.
Blinding
Due to the nature of the intervention, a blinding of partic-
ipants and clinicians is not possible. The collection of data
and analyses will be carried out with blinding of treatment
allocation. All data will be collected through online ques-
tionnaires (SurveyXact) secured on an encrypted server.
Intervention
TAU consists of up to 8–10 sessions of supportive psycho-
therapy. Each of the Suicide Prevention Clinics applies
different or combined therapies including cognitive,
problem-solving, crisis, dialectical behavior, integrated care,
psychodynamic, systemic, psychoanalytic approaches, and/
or social counseling. A uniform treatment algorithm is not
followed; elements are chosen on the basis of what is
deemed the most promising strategy in each individual
case. As an integral part of the therapy, the patient, in
collaboration with the clinician, fills in a safety plan by
reviewing the signs of situations where crises occur and
what has previously worked as strategies of distraction and
help-seeking. The safety plan is presented to the patient
using comparable manual-based instructions. Participants
randomized to the paper format will write the safety plan
on a sheet of paper and keep the original while the clinician
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keeps a copy in the patient’s medical record. Participants al-
located to the intervention will receive supportive psycho-
therapy and a manual-based introduction to the app-based
safety plan MyPlan and will then fill in the app on their
own smartphones (see Fig. 1 and Table 1). All participants
are encouraged to use the app for 15 minutes per day, e.g.,
to evaluate old and develop new strategies. Once the app is
downloaded, it will be accessible for the participants until it
is deleted in the smartphone. This implies that participants
can continue working with the cognitive process of repro-
cessing thoughts and behavior while attending the treat-
ment sessions in the Suicide Prevention Clinic as well as
during the study’s follow-up period. In the follow-up, the
participants will be asked questions regarding adherence to
treatment and use of the safety plan.
Outcomes/assessments
The primary outcome will be measured as the difference
in suicide ideation before entering the trial and after
12 months participation in the trial. This is measured by
the Beck Suicide Ideation Scale (BSS 21-items) [17]. The
BSS is a 21-item self-report questionnaire measuring sui-
cidal thinking [18]. The items are scored on a 3-point
Likert scale ranging from 0 to 2, with a higher score in-
dicating more severe suicidal ideation. This outcome is
considered as a proxy measure for suicide attempts. The
outcome measures are patient-reported and collected by
questionnaires administered via an electronic link sent
to the participants.
Secondary outcomes are hopelessness (measured by
the Beck Hopelessness Scale, BHS) [19] and depressive
symptoms (using the Major Depression Inventory,
MDI); they will be measured before participants enter
the trial and after 3, 6, 9, and 12 months of participation
in the trial (see Table 1). App/user satisfaction will be
measured by a modified user satisfaction Client Satisfac-
tion Questionnaire (CSQ-8).
The BHS consists of 20 true-false items pertaining to
future outlook [20]. The MDI is a short questionnaire
consisting of 12 questions. It captures depressive
Fig. 1 Flow diagram of MyPlan trial
Table 1 SPIRIT time points and assessments [30]
Enrollment and allocation Study period
Time point (month) t0 Treatment t1 t2 t3 t4
(baseline) 3 6 9 12
ENROLLMENT:
Eligibility screen X
Informed consent X
Allocation X
INTERVENTIONS:
MYPLAN app X
Safety plan on paper X
ASSESSMENTS:
Beck Suicide Ideation Scale X X X X X
Beck Hopelessness Scale X X X X X
Major Depression Inventory X X X X X
WHO Quality of life X X X X X
Client Satisfaction Questionnaire (modified) X
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symptoms defined in both the International Statistical
Classification of Diseases and related Health Problems,
10th revision (ICD-10) and the Diagnostic and Statistical
Manual of Mental Disorders, 4th and 5th editions (DSM-
IV/5). It can be scored as a diagnostic tool (an algorithm
makes it possible to make an ICD-10 diagnosis of mild,
moderate, or severe depression or a DSM-IV/5 diagnosis
of major depression), but is also scored according to the
severity of the depressive symptoms by a simple sum of
the item scores [21].We have chosen some exploratory
outcomes that include quality of life measured by the
WHO Well-being Index (WHO-5), self-harm (self-re-
ported, covering nonsuicidal self-injury (NSSI) [22] and
suicide attempts at baseline and in all follow-ups), mortal-
ity, admission to psychiatric or somatic emergency wards,
and other somatic and psychiatric hospital register data.
The WHO-5 [23] is a widely used short questionnaire
to measure quality of life. It consists of five basic and
non-invasive questions which tap into the subjective
well-being of the respondents. It is among the most
widely used questionnaires to assess subjective psycho-
logical well-being [24].
Data management
All the above-mentioned patient reported outcome mea-
sures (PROMs) are collected at baseline and follow-up
through self-administered tablet-/Internet-based ques-
tionnaires. All data from participants are collected
through an Internet-based program, which will be
imported to a local secured drive with limited access,
when the data collection is finished. Follow-ups will be
conducted at 3, 6, 9, and 12 months after date of inclu-
sion. Participants will receive an email with a link to an
online survey. Respondents can log on to a secure data
portal, SurveyXact, with their personal trial ID number,
and answers to questionnaires are collected. Participants
will be randomized at entry in the trial, and the
randomization code will be revealed to the researchers
after the analyses are performed. Therefore, the re-
searchers are blinded during all the analyses.
Furthermore, there will be a continuous data collec-
tion with information about usage of the app (recording
of mood ratings and suicide ideation) in the MyPlan app
intervention group. As a default setting on the app,
mood ratings and questions regarding suicidal ideation
will appear as a pop-up notification when the patient
logs in. Under “settings” the participants can change this
default setting, select time intervals, or deactivate the
function. This information is not personal identifiable
and it is stored in a safe cloud solution. Register-based
outcomes, such as mortality, self-harm, somatic and
usage of somatic and mental health care services will be
assessed at 12 and 24 months by obtaining data ex-
tracted from above-listed registries. The registers include
the Danish National Hospital Register (in Danish: Land-
spatientregisteret) and the Cause of Death Register (in
Danish: Dødsårsagsregisteret).
Power calculation
We expect that participants in the intervention group
will have a mean score that is 2.5 points lower compared
to participants in the TAU group at the follow-up after
12 months. The mean score is based on estimates from
previous studies investigating the short-term interven-
tion’s ability to reduce suicide ideation [25, 26]. Based
on previous publications, we expect a post-intervention
standard deviation of 9. Setting the alpha level to 5%
and the beta level to 10%, we need to include 273 partic-
ipants for each group for a total of 546 participants.
Statistical analysis
The analysis of the primary outcome will be conducted ac-
cording to the intention-to-treat principle: all participants
will be included in final analysis according to group assign-
ment regardless of adherence to treatment. This study has
multiple assessment points, and for the primary analysis we
will use repeated measurements in a mixed model with
unstructured variance [27]. For participants with missing
data in three or more data points, we will identify potential
differences from participants with full data and include these
variables as potential confounders in the secondary analysis.
All statistical analyses will be conducted in SPSS. All
tests will be two-tailed, and p values below 0.05 will be
considered significant and interpreted with respect to
the hierarchy of hypotheses.
Pilot study
A pilot study, as similar as possible to the actual trial,
will be carried out at one of the sites to test feasibility
and technical issues. The rationale for the pilot study is
to detect technical errors and make adjustments before
starting the trial. This will include testing the data col-
lection including the management system and mail re-
minder function as well as the general functionality of
the app. A total of 40 participant will be recruited, 20 in
each arm. The 40 participants will be followed for
3 months, and technical adjustments will be performed
during the pilot study period.
Discussion
The expansive development of mobile phone applications
opens up new opportunities to provide support for patients.
New knowledge and evidence for this type of intervention
are important, especially within the field of suicide preven-
tion. It is reasonable to think that a smartphone application,
which is “at hand” at most times, is more effective than a
safety plan on paper. Beyond being “at hand,” the specific
features of a smartphone might augment the effect of a
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crisis plan, for instance, communication tools, GPS, mem-
ory, and self-assessment tools. The augmenting effects of
smartphone technology on the management of suicidal cri-
ses are not shown yet.
The trial is designed as a pragmatic trial in the clinical
setting of the Danish Suicide Prevention Clinics. The safety
plan is, in combination with supportive psychotherapy, a
mandatory part of the therapy provided in the clinics. Many
of the clinics offer a treatment regime that is based on or
comparable to the Collaborative Assessment and Manage-
ment of Suicidality (CAMS) principles [28, 29].
The fact that suicidal ideation fluctuates over time for
many patients indicates that a tool such as Myplan, which
is available at most times, might be a highly relevant re-
source for people at risk of suicide. Furthermore, the
additional data collection of usage of the app as well as the
recording of mood ratings and suicidal ideation through
MyPlan give us an opportunity to study fluctuations over
time. We will also be able to identify which strategies and
symptoms users most frequently enter in the app.
Trial status
The pilot study will start in April 2017, and the trial is
planned to start in July 2017.
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